NYSE:CORHealthcare
Cencora (COR): Valuation Outlook After Settlement Deal Resolves Major Litigation Overhang
If you have been tracking Cencora (COR) recently, you probably noticed the buzz after the company reached a proposed settlement agreement to resolve its ongoing stockholder derivative lawsuit tied to oversight of its controlled substance diversion programs. This agreement, still awaiting court approval, means insurance carriers will pay a substantial sum directly to Cencora. Perhaps most importantly for investors, the deal contains no admission of liability, suggesting the company can move...